ECSP055657A - Antidepresivos derivados de piperidina de benzodioxanos de heterociclo fusionado - Google Patents

Antidepresivos derivados de piperidina de benzodioxanos de heterociclo fusionado

Info

Publication number
ECSP055657A
ECSP055657A EC2005005657A ECSP055657A ECSP055657A EC SP055657 A ECSP055657 A EC SP055657A EC 2005005657 A EC2005005657 A EC 2005005657A EC SP055657 A ECSP055657 A EC SP055657A EC SP055657 A ECSP055657 A EC SP055657A
Authority
EC
Ecuador
Prior art keywords
disorder
anxiety
heterocicle
benzodioxanes
fusioned
Prior art date
Application number
EC2005005657A
Other languages
English (en)
Inventor
Michael Byron Webb
Gary Paul Stack
Magda Asselin
Deborah Ann Evrard
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP055657A publication Critical patent/ECSP055657A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Gynecology & Obstetrics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Los compuestos de la Fórmula: son útiles para el tratamiento de la depresión (que incluye en forma no taxativa trastorno depresivo mayor, depresión infantil y distimia), ansiedad, trastorno de pánico, trastorno de estrés postraumático, trastonro disfórico premenstural (también llamado síndrome premenstrual), trastorno de déficit de atención (con y sin hiperactividad), trastorno obsesivo compulsivo, trastorno de ansiedad social, trastorno de ansiedad generalizada, obesidad, trastornos alimentarios tales como anorexia nerviosa y bulimia nerviosa, enrojecimiento vasomotor, adicción a la cocaína y al alcohol, disfunción sexual y enfermedades relacionadas.
EC2005005657A 2002-09-12 2005-03-10 Antidepresivos derivados de piperidina de benzodioxanos de heterociclo fusionado ECSP055657A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41003302P 2002-09-12 2002-09-12

Publications (1)

Publication Number Publication Date
ECSP055657A true ECSP055657A (es) 2005-07-06

Family

ID=31994047

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005657A ECSP055657A (es) 2002-09-12 2005-03-10 Antidepresivos derivados de piperidina de benzodioxanos de heterociclo fusionado

Country Status (13)

Country Link
US (3) US6939877B2 (es)
EP (1) EP1537120A1 (es)
JP (1) JP2006510594A (es)
KR (1) KR20050042192A (es)
CN (2) CN101230066A (es)
AU (1) AU2003270559A1 (es)
BR (1) BR0314431A (es)
EC (1) ECSP055657A (es)
MX (1) MXPA05002830A (es)
NO (1) NO20051617D0 (es)
RU (1) RU2005107588A (es)
WO (1) WO2004024733A1 (es)
ZA (1) ZA200502042B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
AU2006214233A1 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
AR060493A1 (es) * 2006-04-18 2008-06-18 Wyeth Corp Derivados de benzodioxano y benzodioxolano. procesos de obtencion.
AU2007334039B2 (en) * 2006-12-21 2012-02-16 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer
CL2008001563A1 (es) * 2007-05-30 2008-10-10 Wyeth6 3 Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
WO2012114347A1 (en) * 2011-02-21 2012-08-30 Avra Laboratories Pvt. Ltd. Synthesis of chiral substituted benzenes and related aromatic compounds containing 1,2 diols protected as diacetal groups

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2266677A (en) * 1941-12-16 Garden implement
US1706658A (en) * 1927-04-15 1929-03-26 Winthrop S Davis Hoe
US3293674A (en) * 1965-04-02 1966-12-27 Sapia James Combination sickle and weed pulling tool
GB1354554A (en) 1970-08-31 1974-06-05 Robins Co Inc A H 2-substituted benzimidazoles
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
CA2075057A1 (en) * 1990-03-15 1991-09-16 Pharmacia & Upjohn Company Llc Therapeutically useful heterocyclic indole compounds
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
KR100251892B1 (ko) 1992-07-13 2000-09-01 디르크 반테 신규한 4-(3-벤조푸라닐)피페리디닐 및 4-(3-벤조티에닐)피페리디닐 유도체 및 이들을 함유하는 약제학적 조성물
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
GB9318431D0 (en) 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
DE19602355A1 (de) * 1996-01-24 1997-07-31 Hoechst Ag Mehrfach fucosylierte Dicarbonsäuren mit antiadhäsiven Eigenschaften
JP2001502327A (ja) 1996-10-15 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション ２，３，８，９―テトラヒドロ―７Ｈ―１，４―ジオキシノ［２，３―ｅ］インドール―８―オンのアザヘテロサイクリルメチル誘導体
US5869490A (en) * 1996-10-15 1999-02-09 American Home Products Corporation Azaheterocyclymethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino (2,3-e) indol-8-one
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) * 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
TWI242011B (en) * 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US6720003B2 (en) * 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
US6458802B1 (en) * 2001-03-14 2002-10-01 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline
US6593350B2 (en) * 2001-04-26 2003-07-15 Wyeth Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans

Also Published As

Publication number Publication date
US7479500B2 (en) 2009-01-20
US6939877B2 (en) 2005-09-06
US20050228009A1 (en) 2005-10-13
WO2004024733A1 (en) 2004-03-25
CN100351256C (zh) 2007-11-28
EP1537120A1 (en) 2005-06-08
CN101230066A (zh) 2008-07-30
AU2003270559A1 (en) 2004-04-30
CN1681820A (zh) 2005-10-12
US20040147523A1 (en) 2004-07-29
MXPA05002830A (es) 2005-08-16
ZA200502042B (en) 2006-08-30
US20090042895A1 (en) 2009-02-12
JP2006510594A (ja) 2006-03-30
NO20051617L (no) 2005-03-31
NO20051617D0 (no) 2005-03-31
BR0314431A (pt) 2005-09-27
KR20050042192A (ko) 2005-05-04
RU2005107588A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
BR0314429A (pt) Derivados de aza-heterociclil-metil antidepressivo e benzodioxanos fundidos por heterociclo
BR0314277A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
AR066210A1 (es) Proceso para producir compuesto amida
ECSP055657A (es) Antidepresivos derivados de piperidina de benzodioxanos de heterociclo fusionado
BRPI0516735A (pt) esquema de sìntese melhorada para lacosamida
DE60201829D1 (de) Azaheterocyclylmethyl derivative des 2,3-dihydro-1,4-dioxino(2,3-f)quinolins als antidepressiva
GT200600392A (es) Produccion por auto-oxidacion de peroxido de hidrogeno a traves de hidrogenacion en un microreactor
ATE448230T1 (de) Für die behandlung von obesitas geeignete tricyclische amidderivate
DE60315843D1 (de) Antidepressive indolalkylderivate von heterozyklisch-kondensierten benzodioxanmethylaminen
ATE556997T1 (de) Verfahren zur herstellung von aminen
AR066760A1 (es) Derivados heteroarilo de benzodioxanos heterociclo-fusionados antidepresivos, composiciones farmaceuticas, procesos de obtencion
WO2002088136A3 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
NO20051770L (no) Antidepressivt virkende cykloalkylaminderivater av heterocykle-kondenserte benzodioksaner
AR057662A1 (es) Inhibidor de la recaptacion doble de serotonina y norepinefrina con alta selectividad y uso del mismo
CR7726A (es) Antidepresivos derivados de indoalquilo de benzodioxan metilaminas de heterociclo fusionado
ATE408054T1 (de) Stanzmesser zur herstellung von halte- und dichtelemente für abgasreinigungsanlagen und methode zur herstellung von halte- und dichtelemente mittels eines stanzmessers
ECSP099045A (es) Sal xinafoato de un compuesto de 5-oxazol-2-il-quinolina sustituido
ATE554854T1 (de) Neues organisch-anorganisches hybridmaterial im- 19 und herstellungsverfahren dafür
ATE528298T1 (de) Verfahren zur herstellung von propylenoxid
ECSP088115A (es) Procedimiento para la preparación de compuestos de 1-[ciano(4-hidroxifenil)metil]ciclohexanol
ATE402136T1 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
CR7723A (es) Derivados de azaheterociclilmetilo de benzodioxanos fusionados con heterociclos antidepresivos
EA201300276A1 (ru) Способ получения tmhq
DK1812366T3 (da) Fremgangsmåde til hydrogenering af ketoner
BR0314280A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo